Corbus Pharmaceuticals Holdings, Inc. , a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases.
Corbus Pharmaceuticals Holdings stock last closed at $33.50, down 5.74% from the previous day, and has increased 271.81% in one year. It has overperformed other stocks in the Biotechnology industry by 2.95 percentage points. Corbus Pharmaceuticals Holdings stock is currently +1,004.52% from its 52-week low of $3.03, and -32.83% from its 52-week high of $49.87.
At the moment, there are 10.49M shares of CRBP outstanding. The market value of CRBP is $351.52M. In the last 24 hours, 142,325 CRBP shares were traded.
How to Buy Corbus Pharmaceuticals Holdings Stock
Wondering how to invest in Corbus Pharmaceuticals Holdings stock? Here's how.
Figure out where to buy Corbus Pharmaceuticals Holdings stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Corbus Pharmaceuticals Holdings stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Choose your payment method and add your information.
Analyze Corbus Pharmaceuticals Holdings stock: The Corbus Pharmaceuticals Holdings ticker symbol is CRBP. Is Corbus Pharmaceuticals Holdings stock a good investment? Should you buy shares of CRBP? How do CRBP's underlying business fundamentals look? Do top analysts think Corbus Pharmaceuticals Holdings is a good buy? Why has CRBP's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if CRBP is a good stock to buy).
Execute your CRBP purchase: Decide if you will purchase CRBP shares at the current market price or use a limit order to purchase CRBP stock at a specific price.
Monitor your investment in CRBP: Create a watchlist to get the latest news on your position in Corbus Pharmaceuticals Holdings shares.
Step 1: Figure out where to buy Corbus Pharmaceuticals Holdings stock
You need an online brokerage account in order to access the NASDAQ market and buy CRBP stock.
A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world markets: From Tech to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in CRBP today.
Once you have identified the best place to buy Corbus Pharmaceuticals Holdings stock, it's critical to evaluate their stock before you invest, so you truly comprehend the risk and opportunity.
Overview of key CRBP info
CRBP Price
$33.50
1w %
-8.29%
1y %
271.81%
5y %
-84.43%
P/E
-3.25x
P/B
-50.91x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$44.60M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$351.52M
Next Earnings
May 7, 2024
Next Dividend
N/A
Corbus Pharmaceuticals Holdings Fundamentals
WallStreetZen was created to help average investors perform more accurate fundamental analysis in minutes instead of hours.
Last year, CRBP revenue was $0.00. In the past five year, CRBP's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 28.62%.
No, Corbus Pharmaceuticals Holdings doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your CRBP purchase
You have two primary order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a specific price limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you require additional help with buying stocks on eToro, click the how to video below:
How much does it cost to buy one Corbus Pharmaceuticals Holdings share?
As of Apr 25, 2024, it costs $33.50 to buy one share of Corbus Pharmaceuticals Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.299 shares of CRBP.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Is now a good time to buy Corbus Pharmaceuticals Holdings stock?
According to 2 Wall Street analysts who monitor Corbus Pharmaceuticals Holdings, their consensus recommendation is to buy Corbus Pharmaceuticals Holdings stock.
What is the best way to buy Corbus Pharmaceuticals Holdings stock?
One way to place an order for Corbus Pharmaceuticals Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.